John G Park

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc Impact of zaleplon on continuous positive airway pressure therapy compliance
    John G Park
    Center for Sleep Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA
    J Clin Sleep Med 9:439-44. 2013
  2. ncbi request reprint Mediastinal lymphangioma: Mayo Clinic experience of 25 cases
    John G Park
    Department of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Mayo Clin Proc 81:1197-203. 2006
  3. pmc Updates on definition, consequences, and management of obstructive sleep apnea
    John G Park
    Division of Pulmonary and Critical Care Medicine, Center for Sleep Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 86:549-54; quiz 554-5. 2011
  4. ncbi request reprint Pneumocystis carinii BCK1 functions in a mitogen-activated protein kinase cascade regulating fungal cell-wall assembly
    Charles F Thomas
    Thoracic Diseases Research Unit, Division of Pulmonary, Critical Care and Internal Medicine, Department of Medicine, 826 Stabile Building, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    FEBS Lett 548:59-68. 2003
  5. ncbi request reprint Obstructive sleep apnea-hypopnea syndrome
    Eric J Olson
    Mayo Clinic College of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Sleep Disorders Center, 200 1st Street SW, Rochester, MN 55905, USA
    Prim Care 32:329-59. 2005
  6. doi request reprint Sleep-disordered breathing and stroke: therapeutic approaches
    Melissa C Lipford
    Department of Neurology, Mayo Clinic, Rochester, MN, USA
    Curr Neurol Neurosci Rep 14:431. 2014
  7. ncbi request reprint Expression analysis of PCSTE3, a putative pheromone receptor from the lung pathogenic fungus Pneumocystis carinii
    Pawan K Vohra
    Thoracic Diseases Research Unit, Division of Pulmonary, Critical Care and Internal Medicine, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Biochem Biophys Res Commun 319:193-9. 2004

Collaborators

Detail Information

Publications7

  1. pmc Impact of zaleplon on continuous positive airway pressure therapy compliance
    John G Park
    Center for Sleep Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA
    J Clin Sleep Med 9:439-44. 2013
    ..To determine whether pretreatment with zaleplon immediately before CPAP titration improves 1-month CPAP adherence in subjects newly diagnosed with OSA...
  2. ncbi request reprint Mediastinal lymphangioma: Mayo Clinic experience of 25 cases
    John G Park
    Department of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Mayo Clin Proc 81:1197-203. 2006
    ..To describe the clinical findings, treatment outcomes, disease recurrence rates, and survival of patients with pathologically confirmed mediastinal and cervicomediastinal lymphangioma...
  3. pmc Updates on definition, consequences, and management of obstructive sleep apnea
    John G Park
    Division of Pulmonary and Critical Care Medicine, Center for Sleep Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 86:549-54; quiz 554-5. 2011
    ..This review focuses on updates in the areas of terminology and testing, complications of untreated OSA, perioperative considerations, treatment options, and new developments in this field...
  4. ncbi request reprint Pneumocystis carinii BCK1 functions in a mitogen-activated protein kinase cascade regulating fungal cell-wall assembly
    Charles F Thomas
    Thoracic Diseases Research Unit, Division of Pulmonary, Critical Care and Internal Medicine, Department of Medicine, 826 Stabile Building, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    FEBS Lett 548:59-68. 2003
    ..Since glucan machinery is not present in mammals, a better understanding of this pathway in P. carinii might aid in the development of novel medications which interfere with the integrity of the Pneumocystis cell wall...
  5. ncbi request reprint Obstructive sleep apnea-hypopnea syndrome
    Eric J Olson
    Mayo Clinic College of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Sleep Disorders Center, 200 1st Street SW, Rochester, MN 55905, USA
    Prim Care 32:329-59. 2005
    ..CPAP is the treatment of choice for most patients. Education, follow-up, and heated humidification may help bolster compliance. Lifestyle modifications, oral appliances, and upper surgeries are additional treatment options...
  6. doi request reprint Sleep-disordered breathing and stroke: therapeutic approaches
    Melissa C Lipford
    Department of Neurology, Mayo Clinic, Rochester, MN, USA
    Curr Neurol Neurosci Rep 14:431. 2014
    ..However, in cases where CPAP therapy is not feasible, it is important for clinicians to be familiar with alternative modalities in treating OSA. ..
  7. ncbi request reprint Expression analysis of PCSTE3, a putative pheromone receptor from the lung pathogenic fungus Pneumocystis carinii
    Pawan K Vohra
    Thoracic Diseases Research Unit, Division of Pulmonary, Critical Care and Internal Medicine, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Biochem Biophys Res Commun 319:193-9. 2004
    ..carinii life cycle stages and examined PCSTE3 expression by immunofluorescence microscopy and flow cytometry, and found PCSTE3 expression exclusively on a population of trophic forms. PCSTE3 receptor expression was not found on cysts...